Can we really grow new blood vessels?

AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trial.

European journal of heart failure·2026

Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction.

American heart journal·2025

Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.

Gene therapy·2011

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

American heart journal·2001

Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?

American heart journal·2001

Clinical outcomes of PTCA in chronic renal failure: a case-control study for comorbid features and evaluation of dialysis dependence.

The Journal of invasive cardiology·2001

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

An innovative technique for facial deformity reconstruction following mucormycosis using three-dimensional printing: a case report.

International journal of surgery case reports·2026

FUS-pen: focused ultrasound-mediated micro-sculpting of label-free cells to create functional co-culture microenvironments.

Lab on a chip·2026

Exogenous matrix-free biomanufacturing of glioblastoma organoids enables autonomous assembly of neurovascular-like structures and extracellular matrix.

Bioengineering & translational medicine·2026

Auricular Cartilage Preservation Through Abdominal Subcutaneous Implantation Following Traumatic Ear Amputation: A Case Report.

Cureus·2026

Treatment of a Symptomatic Carotid Web: A Case Report and Review of the Literature.

Cureus·2026

Inhibition of amyloid β aggregation by venetoclax: a computational and in vitro experimental approach.

RSC advances·2026

Related Experiment Videos

Can we really grow new blood vessels?

Related Concept Videos

AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trial.

Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction.

Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?

Clinical outcomes of PTCA in chronic renal failure: a case-control study for comorbid features and evaluation of dialysis dependence.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

An innovative technique for facial deformity reconstruction following mucormycosis using three-dimensional printing: a case report.

FUS-pen: focused ultrasound-mediated micro-sculpting of label-free cells to create functional co-culture microenvironments.

Exogenous matrix-free biomanufacturing of glioblastoma organoids enables autonomous assembly of neurovascular-like structures and extracellular matrix.

Auricular Cartilage Preservation Through Abdominal Subcutaneous Implantation Following Traumatic Ear Amputation: A Case Report.

Treatment of a Symptomatic Carotid Web: A Case Report and Review of the Literature.

Inhibition of amyloid β aggregation by venetoclax: a computational and in vitro experimental approach.

Related Experiment Videos

Can we really grow new blood vessels?

Related Concept Videos

Related Articles